Department of Molecular Medicine, University of Padova, Via Gabelli 63, 35100, Padova, Italy.
Infectious Diseases Unit, Padova Hospital, Via Giustiniani 2, 35128, Padova, Italy.
BMC Infect Dis. 2018 Dec 19;18(1):683. doi: 10.1186/s12879-018-3591-x.
This longitudinal study described Cytomegalovirus (CMV) DNA, Epstein-Barr (EBV) DNA and human herpesvirus 8 (HHV-8) DNA asymptomatic salivary shedding in HIV-positive men who have sex with men (MSM). We aimed to 1-analyze frequency and persistence of herpesvirus shedding, 2-correlate herpesvirus positivity and HIV viroimmunological parameters and 3-assess the association between HIV-RNA suppression and herpesvirus replication.
Herpesvirus DNA was tested with an in-house real-time PCR in 2 salivary samples obtained at T0 and T1 (24 months after T0). HIV-RNA was evaluated in the 24 months prior to T0 and in the 24 months prior to T1; MSM were classified as successfully suppressed patients (SSPs), viremic patients (VPs) and partially suppressed patients (PSPs). EBV DNA load was classified as low viral load (EBV-LVL, value ≤10,000 copies/ml) and as high viral load (EBV-HVL,> 10,000 copies/ml). Mann-Whitney U test tested the difference of the median between groups of patients. Chi-squared test and Fisher's exact test compared categorical variables according to the frequencies. Kruskal-Wallis test compared continuous data distributions between levels of categorical variables.
Ninety-two patients (median CD4+ count 575 cells/mm3, median nadir 330 CD4+ cells/mm3) were included: 40 SSPs,33 VPs and 19 PSPs. The more frequently single virus detected was EBV, both at T0 and at T1 (in 67.5 and 70% of SSPs, in 84.8 and 81.8% of VPs and in 68.4 and 73.7% of SPSs) and the most frequently multiple positivity detected was EBV + HHV-8. At T1, the percentage of CMV positivity was higher in VPs than in SSPs (36.4% vs 5%, p < 0.001), the combined shedding of HHV-8, CMV and EBV was present only in VPs (15.1%, p = 0.01 respect to SSPs) and no VPs confirmed the absence of shedding found at T0 (vs 17.5% of SSPs, p = 0.01). EBV-HVL was more frequent in VPs than in SSPs: 78.6% at T0 (p = 0.03) and 88.9% at T1 (p = 0.01).
The relationship between uncontrolled plasma HIV viremia and CMV, EBV, and HHV-8 shedding is multifaceted, as demonstrated by the focused association with EBV DNA load and not with its frequency and by the persistent combined detection of two oncogenic viruses as EBV and HHV-8 regardless of HIV virological control.
本纵向研究描述了 HIV 阳性男男性行为者(MSM)无症状唾液中细胞巨化病毒(CMV)DNA、爱泼斯坦-巴尔(EBV)DNA 和人类疱疹病毒 8(HHV-8)DNA 的脱落情况。我们旨在:1. 分析疱疹病毒脱落的频率和持续性;2. 分析疱疹病毒阳性与 HIV 病毒免疫参数的相关性;3. 评估 HIV-RNA 抑制与疱疹病毒复制之间的相关性。
使用内部实时 PCR 在 T0 和 T1(T0 后 24 个月)获得的 2 份唾液样本中检测疱疹病毒 DNA。在 T0 之前的 24 个月和 T1 之前的 24 个月评估 HIV-RNA;MSM 被分类为成功抑制患者(SSP)、病毒血症患者(VP)和部分抑制患者(PSP)。EBV DNA 载量被分类为低病毒载量(EBV-LVL,值≤10000 拷贝/ml)和高病毒载量(EBV-HVL,>10000 拷贝/ml)。Mann-Whitney U 检验检验了各组患者中位数之间的差异。卡方检验和 Fisher 确切检验根据频率比较分类变量。Kruskal-Wallis 检验比较了分类变量水平之间的连续数据分布。
共纳入 92 例患者(中位 CD4+计数 575 个细胞/mm3,中位最低点 330 CD4+个细胞/mm3):40 例 SSP、33 例 VP 和 19 例 PSP。在 T0 和 T1 时,检测到的单一病毒中最常见的是 EBV(在 SSP 中分别为 67.5%和 70%,在 VP 中为 84.8%和 81.8%,在 PSP 中为 68.4%和 73.7%),检测到的最常见的多种阳性是 EBV+HHV-8。在 T1 时,VP 中 CMV 阳性率高于 SSP(36.4% vs 5%,p<0.001),仅在 VP 中发现 HHV-8、CMV 和 EBV 的联合脱落(15.1%,与 SSP 相比,p=0.01),没有 VP 证实了 T0 时未发现的脱落(与 SSP 相比,p=0.01)。T0 时 VP 中 EBV-HVL 比 SSP 更常见:78.6%(p=0.03)和 T1 时 88.9%(p=0.01)。
未控制的血浆 HIV 病毒载量与 CMV、EBV 和 HHV-8 脱落之间的关系是多方面的,这一点可以从 EBV DNA 载量与 EBV 脱落频率之间的重点关联得到证明,而不是从 EBV 病毒载量与 EBV 脱落频率之间的重点关联得到证明,以及无论 HIV 病毒学控制如何,都持续检测到两种致癌病毒 EBV 和 HHV-8 的联合存在。